Alternatives to Kanso Diagnostics

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Leveraging the adaptive immune system to diagnose and treat disease.

HaystackAnalytics is a startup focused on providing AI-powered analytics for software development teams.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Pentaomix develops a breakthrough biopsy imaging modality for unprecedented accuracy in pathology analysis.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Clair Labs develops medical-grade, contact-free vital signs sensing technology powered by deep learning and computer vision for proactive healthcare.

AI-powered diagnostic platform detecting and interpreting inaccessible body infra-sounds for enhanced medical diagnosis.

EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops toilet-integrated diagnostic technology for early health condition detection.

Developing autonomous robotic phlebotomy devices to standardize blood collection and improve patient care.

Developing advanced diagnostic technology to expand global access to healthcare.

Non-invasive device for real-time measurement of LVEDP and other vital hemodynamic indices.

ImmunArray develops and markets novel multi-analyte blood-based tests for complex immune-mediated diseases using its iCHIP microarray platform.

Mon4t develops smartphone-based medical tests for neurological disorders, providing real-time monitoring and feedback to patients and physicians.

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Augmedics uses augmented reality to provide surgeons with 'x-ray vision' for spine procedures.

Develops a computational model of the human body for drug discovery and development.

Global healthcare company using focused ultrasound guided by MRI for therapeutic treatments.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

AI-powered platform for cancer diagnostics in digital pathology.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Developing the first robotic surgery platform for cataracts and widespread eye diseases.

TytoCare provides a Home Smart Clinic solution enabling accessible, high-quality primary care from home through remote physical exams.

Transforms smartphone cameras into medical devices for home urinalysis and digitized wound care.

Digital at-home sleep lab solution for increased clinic efficiency and patient care.

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Develops AI-driven, real-time intraoperative imaging for early lung cancer diagnostics and treatment.

Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer for optimal heart disease treatment.

Clinical reasoning AI engine for scalable, high-value healthcare intake and assessment.

Alcon is a global leader in eye care, providing a broad portfolio of products to enhance sight and improve lives.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Pioneering interactive live holography for medical imaging applications, providing physicians with a unique natural user experience.

Develops multi-spectral imaging solutions for autonomous ophthalmic screening and diagnostics.

Zsquare develops the world's thinnest, high-resolution micro-endoscopes for various medical applications, enabling disposable and cost-effective procedures.

Developing advanced magnetic resonance imaging (MRI) technology for enhanced medical diagnostics.

Harnessing genetic data for digital insights in rare and germline disorders.

Developing CORA, a smart exam for early detection of coronary artery disease.

MedTech company developing a remote monitoring solution for Congestive Heart Failure patients.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

AI-powered platform for streamlining medical equipment procurement in home care.

AI-powered vocal biomarkers for health screening, detection, monitoring, and prediction.

MDacne is a mobile app that uses AI-powered computer vision for real-time acne analysis and provides personalized treatment.

Nevia Bio is a femtech startup focused on early detection of women's health conditions.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

ART Medical develops the smART+ Platform, an ecosystem of software and sensor-based tools to detect, predict, and prevent ICU-acquired complications.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

Developing no-contact guided ablation technology for atrial fibrillation treatment.

Developing a commercial-grade digital X-ray source for real-world medical imaging applications to reduce costs.